According to Prometheus Biosciences's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.15 B a decrease over its 2021 earnings that were of -$89.36 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.17 B | 11.53% |
2022 | -$0.15 B | 61.5% |
2021 | -$89.36 M | 208.04% |
2020 | -$29.01 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Epizyme EPZM | -$0.19 B | 14.06% | ๐บ๐ธ USA |
![]() Akebia Therapeutics AKBA | -$96.81 M | -39.86% | ๐บ๐ธ USA |
![]() Agenus
AGEN | -$0.21 B | 27.97% | ๐บ๐ธ USA |